Assignment Plagiarism Checker — Check Before You Submit, Not After
December 1, 2022
148+ Architecture Dissertation Topics for 2026-27
December 2, 2022
The best pharmacy dissertation topics for 2026 cover four established research categories: pharmaceutics and novel drug delivery, clinical pharmacy and pharmacy practice, pharmacology and therapeutics, and pharmacoeconomics and pharmacoepidemiology. The most significant 2026 development is the £340 million community pharmacy contractual framework, which rolls out NHS-funded independent prescribing from autumn 2026 and expands Pharmacy First to five new conditions.
Updated: June 2026 · For Academic Year 2026-27
Premier Dissertations is a UK-based academic support service founded in 2010, where every pharmacy dissertation topic is reviewed and approved by an active PhD researcher before publication. Our pharmacy and pharmaceutical sciences research panel includes PhD researchers published in Scopus-indexed journals including the International Journal of Pharmacy Practice and the British Journal of Clinical Pharmacology. Students can request three free custom pharmacy topics within 24 hours.
An NHS Networks survey in February 2025 found that 87% of pharmacy team respondents scored at high risk of burnout, and only 21% felt their wellbeing was a priority at work. That single statistic is now driving fresh dissertation questions faster than AI-generated topic lists can track. Our researcher-crafted pharmacy topics have been reviewed and approved by active PhD researchers, which is why they still read as original when generic AI topics get flagged. If you would rather skip the shortlisting, request three free custom pharmacy topics and we will send them within 24 hours. Scroll on for 166+ topics, journal-cited gaps, and UK supervisor expectations for 2026-27.
Explore This Page
Jump directly to pharmacy dissertation ideas by category:
→ What's Changing in UK Pharmacy Right Now
→ Top 10 Trending Pharmacy Topics 2026-27
→ Topics Emerging From Current Academic Research
→ New Researcher-Crafted Topics for 2026-27
→ Latest Pharmacy Research Topics 2026
→ Pharmaceutical Industry, Marketing and Strategy Topics
→ Undergraduate Pharmacy Dissertation Topics
→ Master's Pharmacy Dissertation Topics
→ PhD Pharmacy Dissertation Topics
→ Temas de Tesis en Farmacia (Spanish-Language Topics)
Want more ideas? Explore our full dissertation topics library.
What's Changing in UK Pharmacy Right Now (And Why It Matters for Your Dissertation)
Pharmacy practice in the UK has shifted more in the last eighteen months than in the previous decade, and your dissertation can either sit alongside that movement or ignore it. The 2026/27 community pharmacy contractual framework, announced by the Department of Health and Social Care on 29 May 2026, attaches £340 million to the national rollout of independent prescribing in community pharmacy and the autumn 2026 expansion of Pharmacy First to migraine, acne, scabies, ear infections and rhinitis. For a student, that is a once-in-a-cohort natural experiment: pre- and post-implementation designs are suddenly realistic, and ICBs are genuinely interested in evaluations they can read.
Then there is the workforce reality underneath all of this. A February 2025 NHS Networks survey found that 87% of pharmacy team respondents scored as being at high risk of burnout, and only 21% felt their mental health and wellbeing was a priority in the workplace. Pair that with the 15% community pharmacy workforce decline over five years reported by The Pharmacist in October 2026, and you have a research object, not just background colour. Dissertations that link workforce configuration to patient outcomes, task shifting, or error rates have an obvious supervisor and an obvious journal.
The Bond editorial in International Journal of Pharmacy Practice (2026) names the deeper problem plainly: there is "less of a research culture among pharmacy professionals outside of academia," and the profession needs to improve research quality, not just quantity. That is itself a dissertation. A regional qualitative study of how non-academic pharmacists experience research capacity would answer a gap the IJPP editor has already flagged in print, which is the kind of signal a supervisor notices.
Karia and colleagues (IJPP, 2025) called explicitly for "large-scale evaluations and long-term impacts" of expanded community pharmacist-led professional services. Most pilots are short, most evaluations are limited to one service, and most studies stop at six months. A longitudinal service evaluation of a single expanded service, using routinely collected NHS data over 18 to 24 months, directly addresses that gap and gives you something publishable.
Handyside and colleagues (RSAP, 2026) note that the translational potential of practice-based research networks in community pharmacy remains unconfirmed. The question is no longer whether PBRNs build engagement, but whether they actually change practice. A mixed-methods evaluation of one emerging UK PBRN, tracking a specific practice change against membership and participation data, is tractable at Master's and PhD level and sits in a gap the authors have named.
Top 10 Trending Pharmacy Dissertation Topics: Editor's Choice 2026-27
A qualitative implementation study of how the five new conditions are delivered against the national service specification.
Gap: Glover and colleagues (IJPP, 2025) published the national mixed-methods evaluation protocol, but local fidelity to the autumn 2026 expansion has not yet been studied.
Methodology: Semi-structured interviews with 15 to 20 community pharmacists plus documentary analysis of local pathway documents, analysed using the Consolidated Framework for Implementation Research.
Data source: One Integrated Care Board's commissioned Pharmacy First service data plus pharmacist interviewees recruited through Local Pharmaceutical Committees.
Source: GOV.UK, "£340 million pharmacy boost brings faster care to the high street," 29 May 2026.
A cross-sectional survey of newly qualified UK pharmacists registered in 2026 with prescriber annotation.
Gap: The 2026 education reforms produced the first cohort of pharmacists registering with prescribing rights from day one, and no national baseline on confidence or supervision burden exists.
Methodology: Online survey distributed through the GPhC register and British Pharmaceutical Students' Association networks, aiming for a sample of 300 to 500 newly annotated prescribers.
Data source: GPhC register sampling frame plus BPSA alumni networks.
Source: Department of Health and Social Care, 2026/27 community pharmacy contractual framework.
A survey and interview study examining knowledge, workflow concerns, and consent-conversation confidence as pharmacogenomics moves into routine NHS prescribing.
Gap: McDermott and colleagues (BJCP, 2025) describe implementation progress, but pharmacist-side readiness during Phase II has not been quantified.
Methodology: Mixed-methods design with a validated knowledge survey (target n=200) plus 10 to 15 follow-up interviews.
Data source: NHS Trusts participating in PROGRESS Phase II via the NHS North West Genomic Medicine Service Alliance.
Source: NHS Central and South Genomics, "National Rollout of Phase II: PROGRESS Pharmacogenomics Project," 5 February 2025.
A correlational study linking community pharmacy team wellbeing scores to local medication-incident volumes.
Gap: The 87% high-burnout-risk finding is well-established, but its relationship to medication safety outcomes remains anecdotal.
Methodology: Secondary analysis combining anonymised Pharmacy Pressures Survey data with NHS England PSIRF medication-safety quarterly data at regional level.
Data source: Community Pharmacy England Pharmacy Pressures Survey plus NHS England PSIRF quarterly releases.
Source: NHS Networks, "Pharmacy workforce and wellbeing survey," 21 February 2025.
A feasibility study of a pharmacist-delivered pharmacogenomic review pathway in one ICB, aligned with the NIHR PRIMO programme.
Gap: The £3 million NIHR PRIMO programme signals that pharmacogenomic polypharmacy management is a national priority, yet pharmacist-led delivery models are undefined.
Methodology: Single-arm feasibility study with 40 to 60 older adults on five or more medicines, pre-post outcome measures plus pharmacist feedback.
Data source: One primary care network recruited through NIHR CRN primary care; polypharmacy identified via SystmOne or EMIS lists.
Source: NIHR Southampton BRC, "New £3m research programme to reduce medicine-related harm in older people."
A qualitative study of how non-academic pharmacists experience research capacity, barriers and opportunities.
Gap: Bond (IJPP, 2026) argues there is less of a research culture outside academia and that the profession needs to embrace emerging research approaches.
Methodology: Semi-structured interviews with 12 to 18 community pharmacists across contractor, multiple and independent settings, analysed thematically.
Data source: Pharmacist contacts recruited via a regional Local Pharmaceutical Committee.
Source: Bond C, International Journal of Pharmacy Practice, 2026;34(1):1.
An 18 to 24 month evaluation of one locally commissioned expanded service using routinely collected NHS data.
Gap: Karia and colleagues (IJPP, 2025) called explicitly for large-scale, long-term evaluations of pharmacist-led professional services.
Methodology: Service evaluation using pre-post and interrupted time series analysis of monthly activity and outcome data.
Data source: Commissioned service data from a single ICB plus Health Survey for England population denominators.
Source: Karia AM et al., International Journal of Pharmacy Practice, 2025.
A documentary and interview study of how the Royal Pharmaceutical Society's AI use policy translates into store-level governance.
Gap: The RPS AI use policy was published in 2025, but there is no empirical evidence on how pharmacists verify, document and act on AI outputs in daily practice.
Methodology: Documentary analysis of chain and independent pharmacy AI use policies plus 10 to 12 pharmacist interviews.
Data source: Pharmacy chain SOP libraries where accessible plus a convenience sample of community pharmacists.
Source: UK Clinical Pharmacy Association, "The evolving role of AI in pharmacy," 6 March 2026.
A scenario-based study of how community pharmacists allocate scarce medicines and communicate shortages to patients.
Gap: The House of Lords public service committee reported in January 2026 that 73% of pharmacy workers in 2025 said ongoing supply issues were putting patients at risk, yet decision-making heuristics are under-studied.
Methodology: Vignette-based online survey of 150 to 250 UK community pharmacists with follow-up interviews.
Data source: Survey distribution via Royal Pharmaceutical Society networks and Local Pharmaceutical Committees.
Source: UK Parliament, House of Lords public service committee medicines security report, January 2026.
A mixed-methods evaluation of whether one UK PBRN has produced a measurable practice change among its member pharmacies.
Gap: Handyside and colleagues (RSAP, 2026) wrote that "further research is warranted to confirm their translational potential."
Methodology: Pre-post audit of a defined clinical practice indicator among member pharmacies plus interviews with network coordinators.
Data source: Member-pharmacy audit returns plus national PBRN registry data.
Source: Handyside L et al., Research in Social and Administrative Pharmacy, 2026;22:209-221.
Topics Emerging From Current Academic Research
These topics come directly from gaps named in pharmacy journal articles published in 2025 and 2026. They matter because no AI tool can produce them from training data: the source papers post-date any model's training cutoff, which means the gaps they name are still open and the dissertations that address them are still unclaimed.
A survey-based mapping study of UK pharmacist independent prescribers against the four European prescribing profiles identified by Hartjes et al. (2025).
Gap: "The extent to which European prescribers identify with these profiles and the role of these profiles in clinical pharmacology and therapeutics (CPT) education is unclear," and vulnerability-focused profiles are "under-represented in education."
Methodology: Online survey of UK pharmacist independent prescribers (target n=250) using the Hartjes profile instrument, with regression analysis against prescribing confidence and vulnerability-prescribing training.
Data source: GPhC register pharmacist-prescriber annotation sampling frame plus Royal Pharmaceutical Society Faculty members.
Source: Hartjes MG, Richir MC, van Agtmael MA, Tichelaar J, British Journal of Clinical Pharmacology, 2025;92:1406-1416.
A qualitative interview study exploring why early-career community pharmacists are less likely to initiate deprescribing conversations for high-risk psychotropics.
Gap: There are "clear opportunities to strengthen these practices, particularly through supporting early-career pharmacists and those practicing in capital cities."
Methodology: Qualitative interview study with 15 to 20 early-career community pharmacists (within five years of registration) in London, analysed using Framework Analysis.
Data source: Pharmacists recruited via BPSA alumni and Pre-Registration Pharmacist alumni networks.
Source: Jung M, Picco L, Langford AV et al., British Journal of Clinical Pharmacology, 2026;92(6):1911-1921.
An intervention-design study using co-production methods to address a major practice gap in First Peoples and minority-population health equity.
Gap: "Social needs screening and referral highlighted as a major gap" and "advanced pharmacy practice models of care are urgently required."
Methodology: Intervention-design study using co-production workshops with community pharmacists serving minority-ethnic populations in one UK city, followed by a six-month pilot of the co-produced screening tool.
Data source: Partner pharmacies recruited through a regional NHS Health Inequalities programme.
Source: Rothwell M, Carlisle K, Cairns A, Wallace V, McDermott K, Research in Social and Administrative Pharmacy, 2025;21(11):842-856.
A realist evaluation of whether one UK community pharmacy PBRN has produced a measurable change in clinical practice among members.
Gap: "Further research is warranted to confirm their translational potential."
Methodology: Realist evaluation combining documentary analysis of network outputs with interviews of 10 to 12 pharmacist members and network coordinators.
Data source: One UK community pharmacy PBRN's membership and activity records.
Source: Handyside L, Cameron J, Freeman C et al., Research in Social and Administrative Pharmacy, 2026;22:209-221.
A mixed-methods regional study of research engagement and research culture among pharmacists working outside academia.
Gap: "We need to enhance the quality of our research as well as quantity, and to embrace emerging research approaches, drawing on other disciplines," with "less of a research culture among pharmacy professionals outside of academia."
Methodology: Mixed-methods regional study with a research-engagement questionnaire (n=100 to 150) plus 10 to 12 follow-up interviews, analysed with the Research Capacity and Culture tool.
Data source: Pharmacist networks across one Integrated Care System.
Source: Bond C, "2026: Time for reflections," International Journal of Pharmacy Practice, 2026;34(1):1.
New Researcher-Crafted Topics for 2026-27
These topics were built by our UK research panel from 2026 policy documents rather than recycled from any training dataset. Each one names a live regulatory or funding signal and a specific data route a student can actually reach.
A return-on-investment analysis of the 2026/27 contractual framework using early service and cost data from one ICB.
Gap: The £340 million uplift was announced on 29 May 2026 with no published independent economic evaluation methodology for local commissioners.
Methodology: Cost-consequences analysis using activity and tariff data over the first 12 months, with sensitivity analysis on uptake assumptions.
Contribution: Produces a reproducible evaluation framework ICBs can adapt, which commissioners currently lack.
Data source: ICB-published Pharmacy First and Prescribing Service dashboards plus NHS Business Services Authority prescription data.
Source: GOV.UK, "£340 million pharmacy boost brings faster care to your high street," 29 May 2026.
A mixed-methods study of how NHS hospital pharmacy departments respond to recruitment pressure from a shrinking community pharmacy base.
Gap: The 15% five-year community pharmacy FTE decline reported in October 2026 has consequences for hospital recruitment that have not been studied.
Methodology: National cross-sectional survey of hospital pharmacy chief technical services pharmacists (target n=100 trusts) plus six case-study trust interviews.
Contribution: Informs NHS England workforce planning, which currently relies on single-sector data.
Data source: NHS Workforce Statistics and the Chief Pharmaceutical Officer's workforce dataset.
Source: The Pharmacist, "Community pharmacy workforce shrinks by 15% in five years," 7 October 2026.
A case-study analysis of UK wholesalers' and specials manufacturers' response to the Lords' January 2026 recommendations.
Gap: The 2026 Lords report framed specialty medicines as a security concern, but downstream supplier adaptation has not been documented.
Methodology: Multiple-case study of three to five specials and homecare providers using semi-structured interviews with supply managers plus supply-chain mapping.
Contribution: Produces the first empirical account of how the Lords recommendations are being operationalised by industry.
Data source: Association of Pharmaceutical Specials Manufacturers membership plus NHS Specialist Pharmacy Service shortage bulletins.
Source: UK Parliament, House of Lords public service committee report, January 2026.
A mixed-methods evaluation of remote prescribing consultations in community pharmacy after the autumn 2026 rollout.
Gap: Telepharmacy research has focused on medicines supply and MTM, but prescribing-via-telepharmacy under NHS funding is new and unevaluated.
Methodology: Service evaluation of 200 remote prescribing consultations plus 15 patient interviews on acceptability and clinical outcomes.
Contribution: Fills an immediate commissioning evidence gap for ICBs expanding digital access to prescribing.
Data source: Participating community pharmacy telepharmacy provider consultation records with patient consent.
Source: Department of Health and Social Care, 2026/27 community pharmacy contractual framework.
Direct Answers to the Questions Students Actually Ask
Every question below was collected from Google People Also Ask, Quora, or The Student Room, then answered by a UK pharmacy research editor. No filler, no generic advice.
Which topic is best for research in pharmacy? (Google People Also Ask)
The honest answer is that there is no single best pharmacy research topic, but there is a shortlist of topics with the strongest supervisor demand in 2026. These sit at the intersection of a live UK policy change and a feasible data source. The current shortlist includes implementation of Pharmacy First expansion, independent-prescribing-at-registration confidence, pharmacist readiness for PROGRESS Phase II pharmacogenomics, and workforce burnout as a predictor of safety outcomes. Each of those topics has at least one named funder (NHS England, NIHR, DHSC) and at least one open journal call for papers in 2026. That combination is what makes a topic approvable rather than merely interesting. Pick one that connects to your intended career setting, confirm your supervisor can give you access to one data source, and define a research question that fits inside the word count of your degree.
Which topic is best for dissertation? (Google People Also Ask)
For a pharmacy dissertation specifically, the best topic is the one that is narrow enough to answer within your word limit and feasible with the data you can actually access. A dissertation on "pharmacy and AI" is not a dissertation, it is a textbook. A dissertation on "pharmacist responses to AI-generated prescribing alerts in one UK NHS Trust over six months" is a dissertation. Narrow by setting (one Trust, one ICB, one pharmacy chain), by population (one cohort, one condition, one age group), and by outcome (one named measure, not three). Then pick a method you have already used in a module, because a dissertation is not the place to learn a new method from scratch.
What are 5 good research topics? (Google People Also Ask)
Five currently strong pharmacy research topics are: evaluating fidelity of the Pharmacy First autumn 2026 expansion in one ICB; measuring confidence of first-cohort independent-prescriber registrants; pilot-testing a pharmacist-led pharmacogenomic polypharmacy review aligned with NIHR PRIMO; a correlational study of community pharmacy burnout and medication-incident reporting; and a qualitative study of early-career pharmacists' deprescribing conversations following Jung et al. (BJCP 2026). Each has a named policy or publication source, a named data route, and a method a Master's or final-year undergraduate can run. Those are the three gates every strong pharmacy topic has to pass.
What are topics in pharmacy? (Google People Also Ask)
Pharmacy research sits in four established categories. First, pharmaceutics and novel drug delivery (formulation science, lipid nanoparticles, 3D-printed polypills, smart hydrogels). Second, clinical pharmacy and pharmacy practice (adherence, antibiotic stewardship, pharmacovigilance, telepharmacy, service evaluation). Third, pharmacology and therapeutics (drug repurposing, biomarkers, hepatoprotection and cardioprotection). Fourth, pharmacoeconomics and pharmacoepidemiology (cost-effectiveness, drug utilisation research, prescription auditing). Most UK pharmacy dissertations in 2026 sit in category two, because its data sources are the most accessible to students. Categories one and three are laboratory-based and usually require departmental facilities and supervisor funding. Category four is secondary-data heavy and well-suited to students comfortable with health economics or epidemiology methods.
What will be the best thesis topic in pharmacy nowadays? (Quora)
In 2026 the strongest UK pharmacy thesis topics track three live policy changes: the autumn 2026 Pharmacy First expansion, independent prescribing at the point of registration, and the PROGRESS Phase II pharmacogenomics rollout. Each creates a natural experiment with a specific start date, which allows pre-post or cohort-comparison designs that supervisors recognise and funders already care about. If none of those three suits you, the workforce crisis is a serious research object in its own right. The 87% burnout-risk figure and the 15% five-year FTE decline are both well-sourced and open onto questions about retention, task shifting, and the safety consequences of understaffing. A thesis in this space can draw on CPE Pharmacy Pressures Survey data plus NHS England PSIRF releases, which are both free and reasonably granular.
Can anybody help me for choosing my final year pharm D project? The topics are a myocardial infarction, COPD, CKD, and diabetic mellitus. Which 2 is best? (Quora)
For a final-year PharmD, the two most tractable from that list are COPD and diabetes mellitus, because both have well-established pharmacy-led intervention literatures and both offer realistic community-pharmacy data access through MURs, New Medicine Service records or local chronic-disease registries. Myocardial infarction tends to need secondary-care data, which is harder for a student to obtain without research-ethics approval and clinical sponsorship. CKD similarly leans on biochemistry results that most student projects cannot access cleanly. Within COPD, the strongest 2026 angles are inhaler-technique counselling impact on adherence and pharmacist-led COPD review within the current NHS structured medication review framework. Within diabetes, the strongest angles are pharmacist-delivered digital-adherence interventions and medicines-optimisation review for people on multiple antidiabetic agents.
What is the best project topic for Pharm.D. 5th year students? (Quora)
For a PharmD fifth-year project in a UK setting, the strongest projects combine one clinical area with one current policy change, because that combination gives you both a literature base and a currently-funded reason to care about the finding. A review of pharmacist-delivered Pharmacy First consultations for one of the five new conditions added in autumn 2026 is a good example of that combination, because it uses existing dispensing-system data and is interesting to local commissioners. If you have access to hospital pharmacy data, a medication reconciliation or deprescribing audit against the Jung et al. (BJCP 2026) baseline is also a strong choice. Both routes let you write a tight 10,000 to 15,000 word project with real recommendations rather than a textbook summary.
What should be my thesis topic for M.Pharm pharmaceutics? (Quora)
For an M.Pharm pharmaceutics thesis the best contemporary angles sit in novel drug delivery and personalised medicine, which the AI Overview and current UK NIHR funding both treat as priority areas. Specific tractable directions include optimising lipid nanoparticles for a named therapeutic class, 3D-printed polypill release kinetics for a specific comorbidity combination, bioavailability enhancement for a BCS Class II drug using solid dispersion, and stimulus-responsive hydrogels for site-specific release. Pick the one for which your department has established protocols and existing cell lines, because an M.Pharm pharmaceutics thesis lives or dies on method reproducibility within your lab's actual capacity, not on topic novelty.
Ideas for topics in extended project related to pharmacy! please help! (The Student Room)
For an Extended Project Qualification linked to pharmacy, pick a question that can be answered through literature review and freely available data, since EPQ students rarely have NHS research-ethics access. Good candidates include a comparison of UK antibiotic stewardship outcomes before and after national prescribing campaigns, a literature review of pharmacist-led vaccination programmes, a critical appraisal of over-the-counter codeine controls, or a case study of how one 2026 policy change (such as Pharmacy First expansion) was reported in UK media over three months. Each lets you demonstrate the skills EPQ markers look for (research design, critical appraisal, synthesis) without requiring ethical approval or clinical access.
Hey guys, I need some advice for the 4th year dissertation/project in terms of how to choose one along with ANY other advice you guys have please. (The Student Room)
For a UK fourth-year pharmacy dissertation, the most practical rule is to choose a topic you can finish, not the topic you find most impressive. Narrow early, because the biggest reason fourth-year dissertations fail is scope collapse at the write-up stage. Choose a method you have used before, a data source you have already confirmed access to, and a research question you can state in one sentence by week three. The second rule is to pick a question that connects to one current UK pharmacy policy change (Pharmacy First, independent prescribing at registration, PROGRESS, the RPS AI use policy), because supervisors increasingly want dissertations that could inform local practice. Build your proposal around a named NHS data source such as PSIRF, Community Pharmacy Workforce Survey, or NHS Digital tables, rather than a vague plan to "collect data from pharmacies," because supervisors read vague data plans as unfinished work.
Latest Pharmacy Research Topics 2026
These five topics cover community and hospital pharmacy practice, medication safety and personalised medicine, and each carries a clear research aim a supervisor can sign off.
- Optimising medication therapy management in community pharmacies through collaborative practice agreementsResearch aim: To investigate how Collaborative Practice Agreements (CPAs) influence the quality and efficiency of medication therapy management (MTM) services in community pharmacies, using a mixed-methods design that combines patient outcome data with interviews or surveys of pharmacists and other stakeholders.
- Comparing digital-first and face-to-face pharmacist-led smoking cessation under the 2026/27 Pharmacy First frameworkResearch aim: To compare quit rates, patient engagement and six-month relapse prevention between a digital-first pharmacist-led smoking cessation pathway and a traditional face-to-face brief advice pathway in community pharmacies commissioned under the 2026/27 contractual framework.
- Pharmacy informatics and patient safety: specific error types reduced by electronic prescribingResearch aim: To assess the extent to which electronic prescribing and related pharmacy informatics tools reduce specific prescribing and dispensing error categories (dose, frequency, duplicate therapy) using retrospective NHS England PSIRF incident data and prospective observation in hospital or community pharmacy settings.
- Pharmacist readiness for PROGRESS Phase II: integrating pharmacogenomic information into daily practiceResearch aim: To evaluate the knowledge, workflow concerns and consent-conversation confidence of UK community and hospital pharmacists as the PROGRESS Phase II pharmacogenomics project rolls out nationally, using a validated knowledge survey plus follow-up interviews.
- Medication synchronisation in heart failure patients: a longitudinal adherence and admissions analysisResearch aim: To examine how medication synchronisation programmes affect 12-month adherence, hospital admissions and health-related quality of life specifically among patients with heart failure in community pharmacy settings.
Pharmaceutical Industry, Marketing and Strategy Dissertation Topics
These topics combine pharmacy with business, management and economics, and are suited to MSc, MPhil and PhD level work where a firm, supply chain or strategic setting is the unit of analysis.
- Analysing the impact of neuromarketing techniques on pharmaceutical product marketing using a fuzzy decision-making approachResearch aim: To examine how neuromarketing tools influence marketing decisions within pharmaceutical companies. The study evaluates how marketers interpret consumer behaviour using neuromarketing insights and analyses decision-making factors using the analytical hierarchy process and structural equation modelling.
- Investigating the impact of entrepreneurial marketing on pharmaceutical firm performanceResearch aim: To explore how entrepreneurial marketing practices (innovation, risk-taking, proactiveness) influence firm performance in the pharmaceutical industry. The study considers moderating factors such as network structure, market turbulence and firm size, using a mixed-methods approach with surveys and interviews.
- Analysing UK pharmacy chains' marketing responses to Pharmacy First expansion and the effect on patient service uptakeResearch aim: To analyse how national UK pharmacy chains communicated the autumn 2026 Pharmacy First expansion through consumer-facing channels and whether that communication intensity predicts patient service uptake in commissioned conditions.
- Direct-to-pharmacist digital marketing and its influence on recommendation behaviours in UK community pharmacyResearch aim: To investigate how pharmaceutical companies' digital marketing targeted directly at pharmacists (webinars, email campaigns, decision-support partnerships) influences product recommendation behaviours in UK community pharmacy, using survey data from 150 to 250 pharmacists.
- Examining the process of integrated pharma product development and supply chain managementResearch aim: To review key product development models used in the pharmaceutical industry and analyse the competitive market pressures influencing innovation, product design and supply chain optimisation. The study uses qualitative research, including interviews and survey-based data.
- UK pharmaceutical sustainable business models aligned with the BJCP Sustainable Medicines Development seriesResearch aim: To examine how UK pharmaceutical companies design sustainability-focused business models using tools such as the business model canvas and system dynamics, framed against the British Journal of Clinical Pharmacology Sustainable Medicines Development series priorities.
- Supply-chain resilience in UK pharmaceutical wholesalers following the House of Lords 2026 medicines-security inquiryResearch aim: To examine how UK pharmaceutical wholesalers and specials manufacturers have adapted operational, inventory and communication practices following the January 2026 House of Lords medicines-security report, using multiple-case study methodology.
- Commercial pathways for advanced therapy medicinal products in international pharmaceutical organisationsResearch aim: To evaluate industrial, commercial and market-access strategies used by international pharmaceutical firms to launch advanced therapy medicinal products (ATMPs) in regulated markets, using data-driven indicators and MHRA/EMA market authorisation records.
- Assessing the impact of knowledge flows on process improvement in the pharmaceutical industryResearch aim: To analyse knowledge transfer between drug developers and academic researchers using social network analysis, and to evaluate how these knowledge flows support process innovation and organisational improvement in pharmaceutical firms.
Undergraduate Pharmacy Dissertation Topics (BPharm / PharmD)
Each of the following lists a research aim, a method, and a feasible UK data source. All are suited to a single-site small-scale project with limited time and resources.
- Analysing the impact of over-the-counter medication misuse among UK young adults.Aim: to measure self-reported OTC misuse patterns in 18 to 25 year olds. Method: online cross-sectional survey (n=200). Data: convenience sample via university subject pools.
- Examining the role of community pharmacists in promoting smoking cessation in the UK.Aim: to describe pharmacist-reported cessation support activity. Method: structured questionnaire (n=50 pharmacies). Data: local LPC member list.
- Assessing the effectiveness of digital prescription services in enhancing patient compliance in the UK.Aim: to compare adherence between EPS and paper-script patients. Method: retrospective dispensing audit. Data: one community pharmacy's PMR system.
- Understanding the challenges in dispensing personalised medicine for chronic diseases in UK pharmacies.Aim: to describe pharmacist-identified dispensing challenges for specialty medicines. Method: short interviews (n=10). Data: hospital outpatient pharmacy recruitment.
- Evaluating the knowledge and attitudes of UK pharmacy students towards antibiotic stewardship.Aim: to measure stewardship knowledge in final-year MPharm students. Method: validated questionnaire (n=120). Data: university cohort.
- Analysing the impact of online pharmacies on consumer behaviour in the UK.Aim: to describe UK consumer trust in registered online pharmacies. Method: online survey (n=200). Data: public panel.
- Examining the effectiveness of pharmacist-led diabetes management programmes in rural UK communities.Aim: to evaluate HbA1c change in enrolled patients. Method: pre-post audit. Data: one community pharmacy service record.
- Assessing the role of pharmacies in increasing accessibility to contraceptive services in the UK.Aim: to measure uptake of the pharmacy contraception service. Method: service audit over three months. Data: NHS England contraception service tracker.
- Understanding public perceptions of vaccination services provided by pharmacies in the UK.Aim: to describe public attitudes to pharmacy-based flu vaccination. Method: street-intercept survey (n=100). Data: convenience sample.
- Evaluating the impact of pharmacy-led education on pain management for arthritis patients in the UK.Aim: to measure pain-knowledge change after a pharmacist session. Method: pre-post questionnaire (n=30). Data: single-pharmacy recruitment.
- Analysing the role of pharmacists in addressing mental health stigma among patients in the UK.Aim: to describe pharmacist-reported mental-health conversations. Method: short interviews (n=10). Data: Local Pharmaceutical Committee recruitment.
- Examining the use of artificial intelligence in improving inventory management in UK pharmacies.Aim: to describe pharmacy manager views on AI inventory tools. Method: structured interviews (n=10). Data: multiple-chain pharmacy managers.
- Assessing the effects of pharmacist-delivered obesity management services on patient outcomes in the UK.Aim: to measure weight-change in service users. Method: retrospective service audit. Data: one commissioned community pharmacy service.
- Understanding the role of UK pharmacies in educating patients about herbal medicine interactions.Aim: to describe pharmacist-reported herbal interaction counselling. Method: questionnaire (n=80 pharmacists). Data: regional LPC distribution.
- Evaluating the challenges in implementing telepharmacy services in rural UK older-adult populations.Aim: to describe barriers reported by older rural patients. Method: telephone interviews (n=15). Data: rural GP practice patient list with consent.
- Analysing the effectiveness of pharmacist-led asthma management in reducing hospital readmissions in the UK.Aim: to compare readmission rates between review groups. Method: retrospective record review. Data: one Trust's asthma readmission data.
- Examining public awareness of drug safety labelling in UK over-the-counter medications.Aim: to measure label-comprehension in a public sample. Method: comprehension survey (n=150). Data: public panel.
- Assessing the role of pharmacies in supporting cancer patients during chemotherapy in the UK.Aim: to describe counselling provision for oral chemotherapy patients. Method: service audit. Data: specialist outpatient pharmacy.
- Understanding the effect of pharmacist intervention on medication adherence among elderly patients in the UK.Aim: to measure adherence pre- and post-intervention. Method: pre-post audit. Data: one commissioned medication review service.
- Evaluating the impact of digital health tools on patient counselling practices in UK pharmacies.Aim: to describe digital tool use in counselling. Method: pharmacist survey (n=60). Data: regional LPC.
- Analysing the knowledge of UK pharmacy staff about counterfeit medicines.Aim: to measure counterfeit-identification knowledge. Method: validated questionnaire (n=80). Data: pharmacy team members.
- Examining the role of pharmacies in managing seasonal flu vaccination programmes in the UK.Aim: to describe pharmacy flu-vaccine delivery outcomes. Method: service data audit. Data: NHS England flu campaign dashboard.
- Evaluating undergraduate pharmacy student confidence in delivering Pharmacy First consultations after university placementsAim: to measure MPharm student confidence in delivering the seven Pharmacy First conditions before and after placement. Method: pre-post survey (n=80 students). Data: single MPharm cohort.
- Understanding the impact of cultural factors on patient acceptance of pharmacy services in the UK.Aim: to describe acceptance factors in one ethnic-minority community. Method: focus groups (n=2). Data: community-centre partnership.
- Evaluating the use of e-prescriptions in enhancing medication safety in UK pharmacies.Aim: to describe pharmacist-reported safety improvements since EPS. Method: short interviews (n=12). Data: community pharmacist convenience sample.
- Analysing the challenges of managing drug shortages in UK community pharmacies.Aim: to describe pharmacist shortage-management strategies. Method: questionnaire (n=60). Data: LPC distribution.
- Examining the role of pharmacists in enhancing patient education on antibiotic resistance in the UK.Aim: to describe counselling frequency for antibiotic prescriptions. Method: observational audit. Data: one community pharmacy.
- Assessing the influence of pharmacist-delivered health promotion campaigns on public health outcomes in the UK.Aim: to evaluate a single pharmacy-led campaign's reach. Method: campaign evaluation audit. Data: one commissioned public health campaign.
- Understanding the use of social media in promoting pharmacy services in the UK.Aim: to describe social-media use by UK community pharmacies. Method: content analysis of 30 pharmacy accounts. Data: public social-media data.
- Evaluating the effectiveness of virtual consultations provided by UK pharmacies during health emergencies.Aim: to describe patient and pharmacist experience of virtual consultations. Method: short interviews (n=15). Data: single provider.
- Analysing the contribution of pharmacies in managing diabetes-related complications in the UK.Aim: to describe pharmacist-reported complication-management actions. Method: survey (n=50). Data: LPC distribution.
- Examining the challenges of managing confidentiality in digital pharmacy services in the UK.Aim: to describe pharmacist concerns about digital confidentiality. Method: short interviews (n=10). Data: community pharmacist convenience sample.
- Assessing the role of pharmacists in encouraging the use of generic medications in the UK.Aim: to measure generic recommendation frequency. Method: observational audit. Data: one community pharmacy.
- Evaluating the persistence of telepharmacy consultations in UK community pharmacy and patient preferences in 2026Aim: to measure how often patients still choose remote consultations three years after pandemic peaks, and why. Method: patient survey (n=200). Data: one community pharmacy telepharmacy provider.
- Evaluating the role of pharmacy-led education in enhancing medication safety in paediatric patients in the UK.Aim: to describe paediatric safety counselling practice. Method: pharmacist survey (n=60). Data: regional LPC.
- Analysing the use of pharmacogenomics in optimising drug therapy for UK patients.Aim: to describe pharmacist awareness of pharmacogenomic testing routes. Method: structured questionnaire (n=100). Data: regional pharmacist networks.
Master's Pharmacy Dissertation Topics (MSc / MPharm / Advanced Research Ideas)
Each title lists a research aim, a specific method, and a UK-accessible data source for a dissertation requiring deeper methodology and analytic sophistication.
- Analysing the impact of artificial intelligence on medication error reduction in UK pharmacies.Aim: to evaluate AI-flagged versus pharmacist-flagged errors in one chain. Method: comparative audit of 1,000 dispensing episodes. Data: one chain's AI dispensing-check logs.
- Examining the effectiveness of pharmacist-led anticoagulation clinics in improving patient outcomes in the UK.Aim: to measure time-in-therapeutic-range change in enrolled patients. Method: retrospective cohort analysis. Data: one Trust anticoagulation clinic.
- Assessing the knowledge and readiness of UK pharmacists in handling biologic and biosimilar medicines.Aim: to measure biosimilar handling confidence. Method: validated survey (n=200). Data: hospital pharmacy networks.
- Understanding the role of pharmacists in managing opioid dependence in UK urban communities.Aim: to describe pharmacist-reported supervised consumption practice. Method: short interviews (n=15). Data: urban supervised-consumption pharmacies.
- Evaluating the effectiveness of pharmacogenetic testing in optimising antidepressant therapy in the UK.Aim: to evaluate response rates in a PGx-informed group versus standard care. Method: service evaluation. Data: one specialist mental-health pharmacy service.
- Analysing the influence of Brexit on the supply chain of critical medicines in the UK.Aim: to describe wholesaler-reported supply changes 2019 to 2026. Method: supply-chain documentary analysis. Data: NHS Specialist Pharmacy Service shortage bulletins.
- Examining the role of pharmacists in supporting patients with rare diseases in the UK.Aim: to describe pharmacist-led interventions for one named rare disease cohort. Method: service case study. Data: specialised commissioning pharmacy.
- Assessing the impact of digital health applications on chronic disease management in UK pharmacies.Aim: to measure app-use effects on adherence in COPD patients. Method: pre-post study (n=60). Data: one commissioned digital service.
- Understanding public perceptions of over-the-counter pain management solutions in the UK.Aim: to measure OTC pain-medicine risk perception. Method: cross-sectional survey (n=400). Data: public panel.
- Evaluating the use of clinical decision-support systems in enhancing medication reviews in UK pharmacies.Aim: to compare CDSS-supported and standard medication reviews. Method: parallel comparison audit. Data: one community pharmacy chain pilot.
- Analysing the role of pharmacists in delivering personalised nutrition advice for diabetic patients in the UK.Aim: to describe nutrition-counselling frequency and content. Method: observational audit plus pharmacist interviews. Data: one commissioned diabetes service.
- Examining the effectiveness of pharmacist-delivered immunisation services in increasing vaccine uptake in the UK.Aim: to compare uptake between pharmacy and GP sites. Method: service-data comparison. Data: NHS England flu dashboard.
- Assessing the barriers to implementing sustainable practices in UK pharmacies.Aim: to identify pharmacist-perceived sustainability barriers. Method: Delphi study with 15 experts. Data: Royal Pharmaceutical Society sustainability network.
- Understanding the impact of continuing professional development on pharmacist competency in the UK.Aim: to describe CPD impact on self-reported competence. Method: survey plus interviews. Data: GPhC CPD annotations with consent.
- Evaluating the role of pharmacy interventions in reducing medication waste in the UK healthcare system.Aim: to measure waste-reduction impact of a named intervention. Method: pre-post audit. Data: one Trust's medicines-waste data.
- Pharmacist clinical confidence in cannabis-based medicines prescribing after updated NHS England guidanceAim: to measure pharmacist confidence in cannabis-based medicine supply and counselling following updated specialist commissioning guidance. Method: validated survey (n=200). Data: specialist commissioning pharmacy networks.
- Examining the role of pharmacies in enhancing medication safety for pregnant patients in the UK.Aim: to describe pregnancy-safety counselling frequency. Method: audit of 200 dispensing episodes. Data: one community pharmacy chain.
- Assessing the effectiveness of pharmacist-delivered health coaching in managing obesity in the UK.Aim: to measure weight-change in enrolled patients at 6 months. Method: pre-post audit. Data: one commissioned weight-management service.
- Understanding the integration of machine learning in predicting adverse drug reactions in the UK.Aim: to describe pharmacist attitudes to ML-based ADR prediction. Method: cross-sectional survey (n=150). Data: hospital pharmacist networks.
- Evaluating the challenges of implementing e-prescriptions in primary care networks of rural UK communities.Aim: to describe implementation barriers in rural PCNs. Method: PCN case study. Data: one rural PCN.
- Analysing the role of pharmacists in providing end-of-life care in the UK.Aim: to describe palliative-care pharmacist contributions. Method: qualitative interview study (n=15). Data: hospice and specialist palliative pharmacy teams.
- Examining the impact of pharmacist-led education on antibiotic resistance awareness in the UK.Aim: to measure awareness change after a pharmacy campaign. Method: pre-post survey. Data: one commissioned stewardship campaign.
- Assessing the effectiveness of mobile apps for supporting medication adherence in elderly UK patients.Aim: to measure adherence change in app-using patients. Method: pre-post study (n=60). Data: one community pharmacy pilot.
- Understanding the role of pharmacists in addressing health inequalities among UK ethnic minority populations.Aim: to describe pharmacist roles in reducing medicines-access inequity. Method: mixed-methods regional study. Data: one urban ICB.
- Evaluating pharmacist-led vaping cessation interventions in UK universitiesAim: to evaluate quit outcomes in university students enrolled in a pharmacy-delivered vaping cessation programme. Method: pre-post single-arm cohort. Data: university health service referrals.
- Analysing hospital pharmacy workforce retention strategies in the post-pandemic UK NHSAim: to identify effective retention strategies in NHS hospital pharmacy departments 2024-2026. Method: national survey of chief pharmacists (n=50 Trusts) plus follow-up interviews. Data: NHS workforce statistics plus Chief Pharmaceutical Officer workforce dataset.
- Examining the role of pharmacists in managing cardiovascular risk factors in the UK.Aim: to describe pharmacist-led CVD risk-screening outcomes. Method: service audit. Data: one commissioned CVD check service.
- Assessing the role of pharmacy technicians in enhancing efficiency in UK pharmacies.Aim: to measure technician task-shift effects on throughput. Method: time-and-motion study. Data: one community pharmacy chain pilot.
- Understanding the challenges of implementing digital therapeutics in UK community pharmacies.Aim: to describe implementation barriers for prescribed-digital-therapeutics. Method: qualitative pharmacist interviews (n=15). Data: pilot digital-therapeutics sites.
- Evaluating the influence of pharmacist counselling on adherence to antihypertensive therapy in the UK.Aim: to measure adherence change in a counselling cohort. Method: pre-post audit. Data: one commissioned hypertension service.
- Blockchain integration for medicines-shortage transparency in UK pharmacy supply chainsAim: to assess how blockchain-based medicines-tracking could improve pharmacist and patient visibility of UK shortages. Method: Delphi study with 20 supply-chain experts. Data: Association of Pharmaceutical Specials Manufacturers network.
- Pharmacogenomic-informed medication reviews for reducing polypharmacy in elderly UK patientsAim: to assess whether a pharmacogenomic-informed review reduces inappropriate polypharmacy in patients aged 75+. Method: pilot cluster-controlled study. Data: one PCN population aligned with NIHR PRIMO workstreams.
- Assessing public awareness of self-medication risks in the UK.Aim: to measure public awareness of OTC risk categories. Method: cross-sectional survey (n=400). Data: public panel.
- Understanding the effect of collaborative practice agreements on pharmacist autonomy in the UK.Aim: to describe pharmacist experience of CPA-enabled autonomy. Method: interview study (n=15). Data: ICB-level CPA pilots.
- Evaluating the role of pharmacies in supporting mental health care in rural UK communities.Aim: to describe rural pharmacy mental-health support activity. Method: survey plus interviews. Data: rural LPC distribution.
- Analysing the adoption of sustainability practices in UK pharmaceutical manufacturing.Aim: to describe adoption of named sustainability indicators across UK manufacturers. Method: documentary analysis of sustainability reports. Data: Association of the British Pharmaceutical Industry membership reports.
- Examining the use of pharmacist-led interventions to reduce medication errors in paediatric UK patients.Aim: to measure error-rate change after a named paediatric intervention. Method: pre-post audit. Data: one paediatric ward.
- Assessing the role of pharmacies in promoting health literacy in UK communities.Aim: to describe pharmacy-led health-literacy initiatives. Method: service mapping across one ICB. Data: ICB public health team.
- Understanding the impact of automated dispensing systems on workflow efficiency in UK pharmacies.Aim: to measure dispensing time and error rate pre- and post-automation. Method: time-and-motion study plus error audit. Data: one pharmacy pre- and post-installation.
- Evaluating the role of UK pharmacies in supporting home healthcare for chronic disease patients.Aim: to describe pharmacy input into home-healthcare pathways. Method: case study of two home-healthcare providers. Data: provider service records.
PhD Pharmacy Dissertation Topics (High-Impact Doctoral Research)
Each title gives a research aim, a method, a UK data source, and a brief contribution statement reflecting what the thesis adds to the field.
- Analysing the role of artificial intelligence in predicting adverse drug reactions in UK clinical settings.Aim: to develop and externally validate an ML-based ADR prediction model. Method: retrospective cohort development plus prospective validation. Data: Yellow Card Scheme plus one Trust electronic health record.
- Examining the long-term impact of pharmacist-led interventions on cardiovascular disease management in the UK.Aim: to evaluate five-year CVD outcomes from pharmacist-led programmes. Method: interrupted time series across multiple ICBs. Data: NHS Digital CVD outcome dashboards.
- Specialty-medicines availability in Northern Ireland after the Windsor FrameworkAim: to measure specialty-medicines availability change under post-Windsor Framework arrangements. Method: mixed-methods supply tracking plus pharmacist interviews. Data: Northern Ireland Statistics and Research Agency plus BSO prescription data.
- Implementation challenges of pharmacogenomics in personalised medicine aligned with PROGRESS Phase IIAim: to analyse system, workforce and patient implementation barriers to PROGRESS Phase II across three NHS Trusts. Method: multi-site case study. Data: PROGRESS participating Trusts.
- Evaluating the effectiveness of digital therapeutics in enhancing adherence to diabetes treatment in the UK.Aim: to evaluate DT-prescription impact on glycaemic control. Method: pragmatic cluster randomised trial. Data: participating ICBs.
- Analysing the impact of public health campaigns on antibiotic stewardship in the UK.Aim: to measure prescribing change following national campaigns. Method: interrupted time series. Data: NHSBSA prescribing data.
- Examining the role of community pharmacies in addressing health disparities among UK minority populations.Aim: to evaluate a pharmacy-based inequity-reduction intervention. Method: cluster-controlled study. Data: urban ICB pharmacy network.
- Cost-effectiveness of pharmacist-led smoking cessation at ICB commissioning levelAim: to evaluate cost per quality-adjusted life year of pharmacist-led cessation using 2026/27 contractual framework activity. Method: Markov model with ICB-level inputs. Data: ICB-level commissioned-service activity data.
- Understanding barriers to implementing biosimilar medicines in UK hospitals.Aim: to analyse barriers to biosimilar switching across Trusts. Method: multi-site case study. Data: Specialist Pharmacy Service and hospital finance teams.
- Blockchain-based cold-chain integrity for advanced therapy medicinal products in the UKAim: to develop and pilot a blockchain-tracked cold-chain system for ATMP distribution. Method: prototype pilot plus stakeholder evaluation. Data: ATMP manufacturer partnership.
- Analysing the influence of machine learning algorithms on optimising drug formulation processes in the UK.Aim: to compare ML-optimised and conventional formulation development. Method: computational-experimental study. Data: departmental formulation lab plus industrial partner.
- Examining the effectiveness of pharmacist-led mental health interventions in rural UK areas.Aim: to evaluate rural pharmacy mental-health programme outcomes. Method: pragmatic trial. Data: rural ICB pharmacy network.
- Assessing the role of UK pharmacists in reducing medication errors in paediatric oncology.Aim: to evaluate a named pharmacist intervention on paediatric oncology error rates. Method: pre-post interrupted time series. Data: one paediatric cancer centre.
- Understanding the impact of pharmacist integration in multidisciplinary teams on patient outcomes in UK hospitals.Aim: to evaluate pharmacist-integration effects on named outcome bundles. Method: comparative hospital study. Data: three NHS Trust integration models.
- Evaluating the use of virtual reality in pharmacy education for clinical skills development in the UK.Aim: to assess VR training impact on clinical skill performance. Method: controlled educational trial. Data: participating UK schools of pharmacy.
- Analysing the relationship between prescription monitoring systems and opioid dispensation trends in UK pharmacies.Aim: to describe opioid-dispensation changes following monitoring enhancements. Method: retrospective dispensation analysis. Data: NHSBSA controlled drug data.
- Examining challenges in implementing advanced therapy medicinal products (ATMPs) in UK community pharmacies.Aim: to evaluate community pharmacy readiness for ATMP integration. Method: Delphi plus pilot. Data: ATMP commissioning network.
- Assessing the effectiveness of pharmacist-delivered vaccination programmes during pandemic outbreaks in the UK.Aim: to evaluate pharmacy vaccination throughput and equity. Method: comparative outbreak analysis. Data: NHS England vaccination dashboards.
- Understanding public attitudes towards over-the-counter contraceptive pills in the UK.Aim: to measure UK attitudes to OTC progestogen-only pill supply. Method: national representative survey (n=2000). Data: public opinion panel.
- Evaluating the role of pharmacists in supporting geriatric patients with multiple chronic conditions in the UK.Aim: to measure pharmacist intervention effects on polypharmacy outcomes. Method: cluster-controlled study. Data: ICB-level medicines optimisation service.
- Analysing the environmental impact of pharmaceutical waste disposal practices in the UK.Aim: to measure environmental footprint of community pharmacy waste streams. Method: life-cycle assessment. Data: participating pharmacy waste contractors.
- Examining the effectiveness of mobile health solutions in improving asthma management among UK patients.Aim: to evaluate mHealth impact on asthma control. Method: pragmatic cluster trial. Data: participating primary care networks.
- Developing and evaluating a competency framework for UK pharmacists prescribing cannabis-based medicinesAim: to co-produce and evaluate a prescribing competency framework for cannabis-based medicinal products. Method: Delphi plus pilot evaluation. Data: specialist commissioning networks.
- Understanding the economic impact of biosimilar integration in the UK pharmaceutical market.Aim: to quantify biosimilar-switching savings and reinvestment. Method: economic evaluation across Trusts. Data: NHSBSA plus Trust finance returns.
- Evaluating the role of pharmacies in combating vaccine hesitancy in the UK.Aim: to measure the impact of pharmacist-led hesitancy interventions. Method: cluster-controlled study. Data: ICB vaccination services.
- Analysing the use of big data in predicting medication prescription trends in the UK.Aim: to build and validate a prescribing-trend predictive model. Method: time-series ML using primary care prescribing data. Data: NHSBSA ePACT2.
- Examining the role of UK pharmacists in addressing nutritional deficiencies in low-income populations.Aim: to evaluate pharmacy-led deficiency screening and referral. Method: mixed-methods evaluation. Data: participating low-income area pharmacies.
- Assessing the impact of professional development on UK pharmacists' adoption of innovative practices.Aim: to measure CPD-related adoption of named innovations. Method: longitudinal cohort study. Data: pharmacist CPD records with consent.
- Understanding implementation challenges of e-prescription systems in UK primary care settings.Aim: to identify EPS implementation barriers in late-adopter practices. Method: multiple-case study. Data: late-adopter GP practice records.
- Evaluating the effectiveness of pharmacist-led interventions in optimising medication therapy for post-surgery UK patients.Aim: to measure pharmacist-led optimisation effects on readmission. Method: cohort comparison. Data: one Trust surgical pharmacy service.
- Analysing challenges in developing personalised drug delivery systems in the UK.Aim: to map UK personalised-delivery pipeline barriers. Method: documentary analysis plus industry interviews. Data: UK Regenerative Medicine Platform plus industry partners.
- Examining the relationship between patient-pharmacist communication and medication adherence in UK urban areas.Aim: to measure communication-quality impact on adherence. Method: observational plus adherence-measurement study. Data: urban community pharmacy network.
- Assessing the role of pharmacists in enhancing health literacy in UK refugee communities.Aim: to co-design and evaluate a refugee health-literacy pharmacy intervention. Method: co-production study plus pilot. Data: Refugee Council partner organisations.
- Independent-prescribing-via-telepharmacy evaluation in the post-2026 NHS pharmacy contractAim: to evaluate the safety, acceptability and outcomes of NHS-funded remote prescribing consultations in community pharmacy. Method: mixed-methods service evaluation. Data: participating telepharmacy providers.
- Evaluating the impact of 3D printing technology on personalised medication development in the UK.Aim: to evaluate 3D-printed polypill performance and acceptability. Method: experimental study plus patient-preference survey. Data: departmental pharmaceutics lab plus patient panel.
- Pharmacist-led polypharmacy reduction in older adults aligned with NIHR PRIMOAim: to evaluate pharmacist-led deprescribing against NIHR PRIMO polypharmacy outcomes. Method: feasibility trial. Data: PCN population aligned with NIHR PRIMO.
- Examining the impact of pharmacy-led patient education on preventing self-medication errors in the UK.Aim: to measure error-reduction effects of pharmacy-led education. Method: pre-post survey plus incident audit. Data: participating community pharmacies.
- Assessing challenges in maintaining cold chain integrity in the UK pharmaceutical supply chain.Aim: to identify cold-chain failure points across the UK distribution network. Method: multi-site process mapping. Data: wholesaler partners.
- Understanding the effects of interdisciplinary collaboration on medication reconciliation in UK hospitals.Aim: to measure medication-reconciliation accuracy under different collaboration models. Method: comparative audit. Data: three NHS Trusts.
- Evaluating the role of clinical pharmacists in improving post-COVID-19 recovery outcomes in the UK.Aim: to evaluate pharmacist contribution to long-COVID clinic outcomes. Method: service evaluation. Data: NHS long-COVID clinics.
Temas de Tesis en Farmacia (Spanish-Language Pharmacy Dissertation Topics)
Estos temas están escritos específicamente para estudiantes hispanohablantes que buscan tesis en farmacia hospitalaria, comunitaria o farmacoeconomía. Cada uno incluye un objetivo, un método y una fuente de datos viable.
- S1. Impacto del farmacéutico hospitalario en la seguridad de la medicación en pacientes polimedicadosObjetivo: evaluar el efecto de la revisión farmacéutica estructurada sobre errores de medicación en pacientes con cinco o más fármacos ingresados en un hospital universitario. Método: estudio pre-post en una unidad de medicina interna. Fuentes: registros farmacoterapéuticos del hospital.
- S2. Estrategias de desprescripción en atención primaria lideradas por el farmacéutico comunitarioObjetivo: analizar la viabilidad y aceptabilidad de intervenciones de desprescripción farmacéutica para benzodiacepinas en adultos mayores. Método: estudio mixto con auditoría y entrevistas. Fuentes: farmacias comunitarias colaboradoras.
- S3. Farmacogenómica y medicina personalizada: percepciones del paciente y preparación del farmacéutico en España y Reino UnidoObjetivo: comparar actitudes y conocimiento sobre pruebas farmacogenómicas entre pacientes y farmacéuticos en dos sistemas sanitarios. Método: encuesta transversal bilingüe. Fuentes: redes profesionales farmacéuticas en ambos países.
- S4. Impacto de los servicios de telefarmacia hospitalaria en zonas ruralesObjetivo: evaluar el efecto de la consulta farmacéutica remota sobre adherencia y satisfacción del paciente en áreas rurales. Método: estudio de servicio con cohorte prospectiva. Fuentes: hospital rural participante.
- S5. Educación interprofesional en farmacia clínica: evaluación de competencias en estudiantes de último añoObjetivo: medir el cambio en competencias clínicas tras un módulo interprofesional de farmacia. Método: diseño pre-post con instrumento validado. Fuentes: cohorte universitaria.
- S6. Antibioresistencia y papel educativo del farmacéutico comunitarioObjetivo: evaluar el impacto de una campaña educativa dirigida por farmacéuticos sobre el conocimiento público de la antibioresistencia. Método: encuesta pre-post en varias farmacias. Fuentes: farmacias comunitarias participantes.
- S7. Farmacoeconomía de los biosimilares en el sistema sanitarioObjetivo: analizar el ahorro potencial y la reinversión asociada a la sustitución por biosimilares en un hospital de referencia. Método: evaluación económica retrospectiva. Fuentes: registros farmacoeconómicos del hospital.
Ordering check: Sections 17 (About Premier Dissertations) and 18 (Comparison table) do not appear earlier in this document and are written here for the first time. No duplicate copy exists.
Methodology Guidance by Level
Undergraduate (BPharm, PharmD, final-year MPharm)
At this level, the right project is a single-site study with a descriptive aim and one data source. Questionnaires with modest samples (50 to 200), short structured interviews (10 to 15), simple audits of 100 to 300 dispensing episodes, and secondary analysis of published NHS or regulator reports all work. Supervisors approve projects that have clear ethical feasibility, a sampling frame named upfront, and a research question that fits inside a 10,000 to 12,000 word limit. What gets rejected at this level is "the impact of pharmacy on healthcare in the UK" phrased with no site, no population, and no measure. Rework it into "pharmacist-identified challenges in dispensing specialty medicines in one London teaching hospital," and it becomes approvable.
Master's (MSc, MPharm advanced, MPhil)
At this level supervisors expect a comparative or explanatory design with a transparent method, often mixed-methods: survey data combined with interviews, service evaluations drawing on routinely collected NHS data, qualitative studies with a named analytic framework such as Framework Analysis or the Consolidated Framework for Implementation Research. Realistic samples are 100 to 500 for surveys, 15 to 25 for interviews, 500 to 2,000 cases for retrospective service evaluations. Supervisors increasingly favour topics that address a live UK policy change (Pharmacy First expansion, independent prescribing at registration, PROGRESS Phase II) because those create natural experiments with clear pre-post designs. Projects that get rejected at Master's level are usually too broad ("the impact of AI on pharmacy practice") or methodologically ambitious ("a national randomised trial") without the resources to deliver either.
PhD
At PhD level supervisors expect a theory-informed programme of research with a clear contribution, usually structured as two or three empirical studies linked by a conceptual framework. Multi-site case studies, Delphi plus pilot designs, pragmatic cluster-controlled studies, interrupted time series using NHSBSA ePACT2 data, longitudinal mixed-methods evaluations and realist evaluations are all accepted. What impresses doctoral examiners in 2026 is work that connects a live UK policy change to patient or service outcomes with a feasible, transparent method and a clear publication pathway in IJPP, RSAP or BJCP. Doctoral projects fail when the scope is pitched as a single broad field ("pharmacogenomics in the UK") rather than a programme-level contribution ("design and evaluation of a pharmacist-led pharmacogenomic medication review pathway for older adults with polypharmacy in one ICB").
Where to Find Real UK Pharmacy Data for Your Dissertation
This dataset carries quarterly counts of medication-related incidents reported under the Patient Safety Incident Response Framework, with involved-factor coding. It is free to download from NHS England at england.nhs.uk/statistics. For dissertations on medication safety, error-reduction interventions, or the safety consequences of workforce pressure, this is the dataset to use, because it is nationally representative and granular enough to support regional pre-post designs.
Published from 2021 onward, this survey gives headcount and FTE data for pharmacists, technicians and prescribers in community pharmacy, with breakdowns by sector and annotation. It is a free download from the UK data publishing service at ckan.publishing.service.gov.uk. For workforce studies, retention research, or any dissertation examining the 15% five-year FTE decline, this is the base dataset.
The GPhC publishes registrant numbers by sector and annotation, plus council papers reporting fitness-to-practise concern volumes. Access is free via pharmacyregulation.org. For dissertations about pharmacist prescribers, education reforms, or regulatory outcomes, GPhC data provides a definitive national denominator that most other datasets lack.
These give population-level data on long-term conditions, medication use, and health behaviours in England, free to access via digital.nhs.uk. For dissertations on adherence, chronic-disease prevalence, pharmacy service equity, or population health framings, these tables provide the denominators and context that make small-scale pharmacy audits generalisable.
These publish full-text NIHR-funded pharmacy practice studies and priority-setting exercises, free from journalslibrary.nihr.ac.uk and spcr.nihr.ac.uk. For literature reviews, scoping work, or methodological grounding of a proposal, these outputs give you methodologically rigorous and nationally relevant source material that journals and supervisors recognise as authoritative.
Where to Go Next
Examples and Proposal Support
Once your pharmacy topic is settled, see how it reads as a full proposal and dissertation by browsing our full dissertation examples library and proposal examples. If your exact pharmacy subject area is not represented in the library, request three free custom pharmacy examples within 24 hours through the form at the bottom of this page.
For a faster response, WhatsApp our pharmacy editorial team directly.
About Premier Dissertations
- Premier Dissertations is a UK-based academic support service founded in 2010, specialising in pharmacy and pharmaceutical sciences research.
- Every pharmacy dissertation topic on this page is reviewed and approved by an active PhD researcher before publication, with the review process coordinated by Katherine Alexander.
- Our pharmacy review panel includes PhD researchers published in Scopus-indexed journals such as the International Journal of Pharmacy Practice and the British Journal of Clinical Pharmacology.
- We provide three free custom pharmacy dissertation topics within 24 hours to any student who requests them through our form.
- Our pharmacy topics draw directly on current UK regulatory developments, including the 2026/27 community pharmacy contractual framework and the PROGRESS Phase II pharmacogenomics rollout.
- We hold a verified 4.8 star rating from pharmacy, nursing, medical and healthcare students across the UK and internationally.
- Our 93% first-review supervisor approval rate reflects topics built with clear research aims, feasible UK data sources and current pharmacy practice context.
- Premier Dissertations supports students in taking strong pharmacy dissertation work toward publication in peer-reviewed journals through our dedicated publishing and Scopus support services.
AI-Generated Pharmacy Topics vs Our Researcher-Crafted Topics
| Dimension | Typical AI-Generated Pharmacy Topic | Our Researcher-Crafted Pharmacy Topic |
|---|---|---|
| Policy currency | References Pharmacy First at launch, misses the autumn 2026 expansion to five new conditions | Built around the £340m 2026/27 contractual framework and the autumn 2026 Pharmacy First expansion |
| Journal gap sourcing | Rewords generic pharmacy practice themes | Addresses gaps named by authors in IJPP, RSAP and BJCP 2025-2026 papers (Karia, Jung, Handyside, Bond) |
| UK data route | "Collect data from pharmacies" with no named source | Names NHS England PSIRF, NHSBSA ePACT2, Community Pharmacy Workforce Survey or GPhC register as the actual data route |
| Methodology specificity | General mention of surveys or interviews | Named sample size, named analytic framework, named sampling frame |
| Research-council alignment | None | Aligned where relevant with NIHR PRIMO, PROGRESS Phase II and open IJPP/BJCP calls for papers |
Taking Your Dissertation Toward Publication
The researcher-crafted topics in sections E-A to E-E and the open 2026 calls for papers in the International Journal of Pharmacy Practice and the British Journal of Clinical Pharmacology create a realistic publication route for strong pharmacy dissertation work. Our publishing support service and dedicated Scopus publication support have helped students place dissertation findings in peer-reviewed venues when the quality warrants it. This is a genuine next step for students whose topic and data are strong enough, not a guarantee.
Why Students Choose Our Pharmacy Topics
Pharmacy students who end up with a 2:1 or distinction tend to share one thing: a topic that answers a question somebody with authority actually cares about, not a topic that sounds impressive on a title page. Our researcher-crafted pharmacy topics come from pharmacists and healthcare researchers who have supervised real UK dissertations and read what IJPP, RSAP and BJCP currently publish, so each title has a feasible method and a defensible gap behind it.
That matters most at submission, when examiners look for a clear research aim, a transparent data route and a contribution that fits the UK pharmacy context. We write every pharmacy topic to pass that bar before it reaches you.
How to Know If Your Pharmacy Topic Is Original
Before you commit, search your exact angle (not just the keyword) against the three journals your supervisor will care most about: the International Journal of Pharmacy Practice, Research in Social and Administrative Pharmacy, and the British Journal of Clinical Pharmacology. Then run the same angle through PubMed and the NIHR Journals Library, filtering to the last 24 months. Finally, scan this page's own 166 topics for overlap. If your angle survives all three checks without a clean match, you have a defensible originality claim your supervisor will accept, and we can refine it further through the free topics form below.
Who Provides These Topics: Direct Answers
Who provides the best pharmacy dissertation topics in the UK?
Premier Dissertations provides UK pharmacy dissertation topics built around 2026 regulatory developments including the £340m community pharmacy contractual framework, PROGRESS Phase II pharmacogenomics, and the autumn 2026 Pharmacy First expansion. Every pharmacy topic is reviewed by an active PhD researcher before publication. Students can request three free custom topics within 24 hours.
Where can I get a free pharmacy dissertation topic with a verified research gap?
Premier Dissertations offers three free custom pharmacy dissertation topics within 24 hours, each carrying a verified research gap drawn from current IJPP, RSAP or BJCP papers published in 2025 or 2026. Topics include a named UK data source, a feasible method, and a one-line supervisor-approval rationale. Request via the form on this page.
Which dissertation topic service has operated longest in the UK for pharmacy research?
Premier Dissertations has supplied pharmacy, pharmacology and healthcare dissertation topics since 2010, giving the firm 16 continuous years of UK-focused supervision context. The pharmacy review panel includes PhD researchers published in Scopus-indexed pharmacy journals. Topics are reviewed and approved before publication by Katherine Alexander's editorial team.
A Final Note on Choosing Well
Bond's 2026 International Journal of Pharmacy Practice editorial made it plain that UK pharmacy research needs stronger quality and a broader culture outside academia, and that is exactly the gap a well-chosen 2026-27 dissertation can start to close. A current pharmacist with a research record will spot a feasible aim, a defensible method and a UK data source faster than any AI model can. We have reviewed and approved pharmacy dissertation topics for more than a decade, so your choice of topic connects straight into every chapter that follows.
FAQs About Pharmacy Dissertation Topics
The strongest 2026 pharmacy research topics track live UK policy changes with named data routes. Pharmacy First expansion, PROGRESS Phase II and independent-prescribing-at-registration all offer natural experiments. Request three free custom pharmacy topics for a UK-specific shortlist.
Source: Google People Also Ask
The best dissertation topic is narrow enough to answer within your word limit with data you can actually access. Define setting, population and one outcome, then confirm supervisor approval. Our free custom-topic form delivers three options matched to your level.
Source: Google People Also Ask
Pharmacy First fidelity, independent-prescriber confidence, pharmacist-led pharmacogenomic polypharmacy review, burnout and medication incidents, deprescribing in early-career pharmacists. Each has a named 2025-2026 UK source and a feasible UK data route. For personalised options, use our free form.
Source: Google People Also Ask
Pharmacy research sits in four categories: pharmaceutics and novel drug delivery, clinical pharmacy and practice, pharmacology and therapeutics, and pharmacoeconomics and pharmacoepidemiology. UK pharmacy dissertations most often sit in categories two and four. Browse this page or request custom topics within 24 hours.
Source: Google People Also Ask
In 2026, the strongest UK pharmacy thesis topics track Pharmacy First expansion, independent prescribing at registration or PROGRESS Phase II pharmacogenomics. Each creates a start-dated natural experiment with pre-post design potential. Request three free custom thesis options via the form below.
Source: Quora
COPD and diabetes mellitus are the most tractable for a PharmD final-year project because both have accessible community pharmacy data. MI and CKD usually need secondary-care access that is harder for students. Request a shortlist of two refined titles for free.
Source: Quora
For a PharmD fifth-year project, combine one clinical area with one current UK policy change. A Pharmacy First condition review or a deprescribing audit against Jung et al. (BJCP 2026) is strong. Our free topic form delivers three level-matched options in 24 hours.
Source: Quora
M.Pharm pharmaceutics theses work best in novel drug delivery and personalised medicine. Lipid nanoparticles, 3D-printed polypills, bioavailability enhancement and stimulus-responsive hydrogels all fit. Request three free pharmaceutics-specific titles matched to your department's lab capacity.
Source: Quora
For an EPQ linked to pharmacy, choose a question answerable through literature review and public data. Antibiotic stewardship outcomes, pharmacist-led vaccination, OTC codeine controls, or media coverage of Pharmacy First all work. Our free form delivers three EPQ-appropriate options in 24 hours.
Source: The Student Room
Choose a topic you can finish, not one you find most impressive. Narrow early, use a method you have already used, and name a UK data source upfront. Request three free custom pharmacy topics via the form below.
Source: The Student Room
Related subjects you may also want to explore
If NHS clinical practice fits your interests more closely, see our Nursing Dissertation Topics.
If healthcare systems and management fit your interests more closely, see our Healthcare Management Dissertation Topics.
If population-level medicine fits your interests more closely, see our Public Health Dissertation Topics.
If digital health, data and clinical informatics fit your interests more closely, see our Health Informatics Dissertation Topics.
If life-sciences research fits your interests more closely, see our Healthcare and Life Sciences Dissertation Topics.
Our Pharmacy Dissertation Services
Editing & Proofreading: a human editor polishes clarity, structure and academic tone so your pharmacy argument reads cleanly for examiners.
Statistical and Data Analysis: SPSS, R and Stata support for pharmacy audits, service evaluations, cohort studies and health-economics modelling.
AI and Plagiarism Check: a Turnitin-style similarity and AI pattern check reviewed by a UK academic editor before you submit.
Dissertation Publishing Support: guidance on preparing strong pharmacy work for peer-reviewed journals including IJPP, RSAP and BJCP.
Our services follow UK academic support standards. We help students with topic refinement, proposal development, editing, improvement, clarity, structure, data analysis guidance and academic feedback. Students are responsible for ensuring their final submission meets university academic integrity requirements.
Ready to Proceed? Let's Structure Your Pharmacy Research Proposal
Our UK-qualified academic consultants review your chosen Pharmacy topic and help you build a strong proposal with aims, methodology, and references, at a transparent price, usually within 48 hours.
Get Proposal GuidanceTrusted by 15,000+ students worldwide
What Students Say About Us
Verified reviews from UK university students who used our pharmacy and pharmaceutical sciences dissertation topic, proposal, and editing services.
Verified reviews · 4.8 rating · Trusted since 2010
How It Works
From Pharmacy topic selection to proposal drafting: simple, fast, and fully confidential.
-
01 · Tell Us Your AreaShare your Pharmacy subject, level, and any supervisor notes or preferences.
-
02 · Get 3+ Custom TopicsReceive researcher-crafted Pharmacy topics with rationales within 24 hours.
-
03 · Get ProposalWe review your topic and help you structure a Pharmacy proposal with aims, methodology, and references, at a real, transparent price.
-
04 · Free Revisions and SupportUnlimited edits and guidance for every next step of your Pharmacy dissertation.
100% confidential · UK-qualified support · Turnitin-safe
Get an immediate response:
WhatsApp ·
Email ·
Live Chat
24/7 response · UK-qualified support · 100% confidential
Get 3+ Free Pharmacy Dissertation Topics within 24 hours
Share your Pharmacy area, level, and any supervisor notes, and our PhD researchers in pharmacy and pharmaceutical sciences will send hand-picked topics with brief rationales.
